Pembrolizumab | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.03.2024 | Case report

Pembrolizumab

Granulomatous appendicitis, dermatitis and encephalopathy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Anzeige

Tran HV, et al. Granulomatous Appendicitis, Dermatitis, and Encephalopathy: A Unique Case of Immune-Related Adverse Events in a Woman With Breast Cancer Treated With Pembrolizumab. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A5228 [abstract]

Titel: Pembrolizumab
Granulomatous appendicitis, dermatitis and encephalopathy
Publikationsdatum: 01.03.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-54242-6